Acorda Therapeutics (ACOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACOR | AMGN | BMY | GILD | VRTX |
| Company | Acorda Therapeutics | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.7800 | 318.72 | 53.40 | 84.34 | 454.98 |
| High | 0.8500 | 320.74 | 54.01 | 84.96 | 458.14 |
| Low | 0.6116 | 316.43 | 53.30 | 83.98 | 452.62 |
| Last | 0.6610 | 319.66 | 53.96 | 84.59 | 455.31 |
| Change | -0.2187 | +2.18 | +0.36 | +0.42 | +1.76 |
| % Change | -24.86% | +0.69% | +0.67% | +0.50% | +0.39% |
| Volume | 416,900 | 1,467,800 | 12,831,800 | 4,054,300 | 781,700 |
| 20-Day Average Volume | 396,280 | 2,096,945 | 13,111,021 | 7,713,830 | 966,380 |
| Previous Close | 0.8797 | 317.48 | 53.60 | 84.17 | 453.55 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 8.1538 | 327.11 | 50.49 | 83.17 | 469.25 |
| 20-Day Raw Stochastic | 0.37% | 27.77% | 91.70% | 88.18% | 8.05% |
| 20-Day Relative Strength | 20.79% | 45.19% | 67.65% | 67.32% | 40.75% |
| Weighted Alpha | -37.54 | +18.06 | +4.40 | +19.44 | +21.44 |
| Today's Opinion | 100% Sell | 24% Buy | 88% Buy | 88% Buy | 8% Buy |
| Previous Opinion | 100% Sell | 24% Buy | 88% Buy | 88% Buy | 8% Buy |
| Last Month's Opinion | 24% Sell | 64% Buy | 56% Buy | 88% Buy | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -60.65% since 04/04/24 | -0.93% since 09/27/24 | +5.99% since 09/27/24 | +1.17% since 09/27/24 | -1.64% since 09/27/24 |
| Low | 0.6116 on 04/11/24 | 315.46 on 10/03/24 | 51.03 on 09/30/24 | 82.82 on 10/01/24 | 452.26 on 10/03/24 |
| High | 1.6214 on 04/05/24 | 323.23 on 09/30/24 | 54.54 on 10/02/24 | 85.43 on 10/02/24 | 472.31 on 10/01/24 |
| 1-Month | |||||
| %Chg | -94.49% since 03/11/24 | -3.32% since 09/04/24 | +8.01% since 09/04/24 | +6.90% since 09/04/24 | -4.86% since 09/04/24 |
| Low | 0.6116 on 04/11/24 | 312.16 on 09/25/24 | 47.55 on 09/09/24 | 77.74 on 09/05/24 | 452.26 on 10/03/24 |
| High | 14.1100 on 03/15/24 | 339.17 on 09/23/24 | 54.54 on 10/02/24 | 85.43 on 10/02/24 | 490.15 on 09/16/24 |
| 3-Month | |||||
| %Chg | -95.96% since 01/11/24 | +3.32% since 07/03/24 | +34.70% since 07/03/24 | +27.03% since 07/03/24 | -3.18% since 07/03/24 |
| Low | 0.6116 on 04/11/24 | 306.59 on 08/07/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 452.26 on 10/03/24 |
| High | 18.0000 on 01/18/24 | 346.85 on 07/25/24 | 54.54 on 10/02/24 | 85.43 on 10/02/24 | 510.64 on 08/01/24 |
| 6-Month | |||||
| %Chg | -93.85% since 10/11/23 | +19.24% since 04/04/24 | +4.98% since 04/04/24 | +21.62% since 04/04/24 | +12.70% since 04/04/24 |
| Low | 0.6116 on 04/11/24 | 260.68 on 04/19/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 |
| High | 18.0000 on 01/18/24 | 346.85 on 07/25/24 | 54.54 on 10/02/24 | 85.43 on 10/02/24 | 510.64 on 08/01/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 821 | 171,476,816 | 109,382,312 | 105,386,704 | 117,494,112 |
| Shares Outstanding, K | 1,242 | 536,435 | 2,027,100 | 1,245,853 | 258,053 |
| Annual Sales | 117,630,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -252,850,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 37,990,000 | 8,388,000,000 | 12,201,000,000 | 6,954,000,000 | 2,645,600,000 |
| Last Quarter Net Income | -217,760,000 | 746,000,000 | 1,680,000,000 | 1,614,000,000 | -3,593,600,000 |
| 60-Month Beta | 1.40 | 0.61 | 0.46 | 0.18 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | -175.32 on 04/01/24 | 4.97 on 08/06/24 | 2.07 on 07/26/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 |
| Latest Earnings Date | 05/09/24 | 10/30/24 | 10/31/24 | 11/07/24 | 11/04/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.600 on 10/04/24 | 0.770 on 09/13/24 | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 10/04/24 | 09/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.07 | 39.56 | 17.91 | 0.00 |